Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-human tim3 antibody or functional fragment thereof and application thereof

A functional, antibody technology, applied in the fields of biomedicine and antibody engineering, can solve problems such as incomplete activation of the immune system, achieve high sensitivity and specificity, broad development prospects, and improve accuracy.

Active Publication Date: 2021-11-30
BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV +1
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Immunotherapy provides a new way for tumor treatment. Antibody drugs represented by PD1 / PDL1 and CTLA4 immune checkpoint inhibitors have benefited some tumor patients, but most patients show no initial response to the drug or patients with partial response still develop tumors progression, which may be related to the presence of other immunosuppressive molecules and incomplete activation of the immune system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human tim3 antibody or functional fragment thereof and application thereof
  • Anti-human tim3 antibody or functional fragment thereof and application thereof
  • Anti-human tim3 antibody or functional fragment thereof and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0075] Example 1: Preparation of mouse anti-human Tim3 monoclonal antibody

[0076] (1) Animal immunity

[0077]The experimental animals were female Balb / c mice aged 6-8 weeks, which were purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. After feeding for a week without any abnormality, they will be numbered. About 0.1 ml of blood was collected through the retro-orbital venous plexus. After standing at room temperature for 1 hour, overnight at 4°C, the supernatant serum was collected after centrifugation at 1500g, and stored at -20°C for future testing. For basic immunization, 100 μg / 100 μl of Tim3-His recombinant protein (ACRO Biosystems Company) was emulsified and mixed with an equal volume of Freund’s complete adjuvant (Sigma Company, product number F5881), and the immunization was performed by multi-point subcutaneous injection on the abdomen and back. The booster immunization was carried out at intervals of 3 weeks, and the same amount of Ti...

Embodiment 2

[0086] Example 2: Tim3 antibody sequence analysis

[0087] Amino acid sequence analysis of antibody variable regions Screening of phage antibody library by scFv confirmed four Tim3 monoclonal antibodies named MsT001, MsT065, MsT229 and MsT286.

[0088] Positive clones were sequenced to obtain light chain and heavy chain variable region sequences.

[0089] Through the analysis of IGBLAST software (https: / / www.ncbi.nlm.nih.gov / igblast / ), it was found that the scFv antibody belongs to VH category and Vκ type; ABodyBuilder software (http: / / opig.stats.ox.ac.uk / webapps / newsabdab / sabpred / abodybuilder / ) in Kabat mode to further analyze the positions of the three CDR regions of each antibody VH (heavy chain variable region) and VL (light chain variable region).

[0090] The CDR sequences of the antibody heavy chain variable region are shown in Table 1 below.

[0091] Table 1

[0092]

[0093]

[0094] The amino acid sequence of the heavy chain variable region is as follows (t...

Embodiment 3

[0142] Example 3 Antibody Expression and Purification Identification

[0143] The same antibody light chain and heavy chain expression vectors were transiently transfected into 293 cells at the same time, and the culture supernatant was collected 6-7 days after transfection, and purified by protein A purification column for affinity purification to obtain purified antibodies. The molecular weight of the antibody was predicted by the protein molecular weight calculator, and the purity and molecular weight of the antibody were identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).

[0144] SDS-PAGE electrophoresis detection process: Take 5 μg of purified antibody, respectively, under non-reducing conditions (protein electrophoresis loading buffer without adding β-mercaptoethanol, samples are not boiled) and reducing conditions (protein electrophoresis loading buffer with β-mercaptoethanol, samples Boil for 5min), use 10% SDS-PAGE gel for electrophore...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The present invention provides an anti-human Tim3 antibody or its functional fragment and application thereof. The present invention obtains an anti-human Tim3 antibody with good specificity, high affinity and sensitivity from a phage antibody library, and the anti-human Tim3 antibody obtained by the present invention can specifically recognize and bind soluble Tim3 and cell membrane surface Tim3 protein.

Description

technical field [0001] The invention relates to the technical fields of biomedicine and antibody engineering, in particular to an anti-human Tim3 antibody or a functional fragment thereof and applications thereof. Background technique [0002] Immunotherapy provides a new way for tumor treatment. Antibody drugs represented by PD1 / PDL1 and CTLA4 immune checkpoint inhibitors have benefited some tumor patients, but most patients showed no initial response to the drug or patients with partial response still developed tumors progression, which may be related to the presence of other immunosuppressive molecules and incomplete activation of the immune system. Screening and combining new immunotherapy targets to optimize treatment strategies is a major development trend of current cancer treatment. [0003] T-cell immunoglobulin and mucin domain-3 (T-cell immunoglobulin and mucin domain-3, Tim3; also known as HAVCR2) is one of the most popular immunosuppressive molecules after PD1 / ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/28C12N15/13G01N33/564G01N33/574G01N33/569G01N33/576G01N33/577
CPCC07K16/2803C07K2317/33C07K2317/52C07K2317/56C07K2317/565C07K2317/64C07K2317/92G01N33/564G01N33/56983G01N33/56988G01N33/574G01N33/57492G01N33/5767G01N33/577G01N2333/70503
Inventor 闫卓红张洪涛王小珏易玲
Owner BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV